# The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients

> **NCT04088448** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sadat City University** · enrollment: 80 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Placebo oral tablet
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04088448
- **Lead sponsor:** Sadat City University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04088448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04088448, "The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04088448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*